Clear Street’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$62.7K Hold
62,666
﹤0.01% 696
2025
Q4
$21.3K Hold
62,666
﹤0.01% 712
2025
Q3
$21.6K Hold
62,666
﹤0.01% 621
2025
Q2
$15K Hold
62,666
﹤0.01% 479
2025
Q1
$14.9K Hold
62,666
﹤0.01% 335
2024
Q4
$13.2K Buy
62,666
+12,221
+24% +$2.5K ﹤0.01% 320
2024
Q3
$9.59K Hold
50,445
﹤0.01% 395
2024
Q2
$11.5K Hold
50,445
﹤0.01% 417
2024
Q1
$12.6K Hold
50,445
﹤0.01% 372
2023
Q4
$9.72K Hold
50,445
﹤0.01% 369
2023
Q3
$13.4K Hold
50,445
﹤0.01% 480
2023
Q2
$19.9K Hold
50,445
﹤0.01% 585
2023
Q1
$16.5K Hold
50,445
﹤0.01% 408
2022
Q4
$13K Hold
50,445
﹤0.01% 462
2022
Q3
$22K Hold
50,445
﹤0.01% 461
2022
Q2
$24K Buy
50,445
+10,445
+26% +$5.82K ﹤0.01% 371
2022
Q1
$24K Buy
+40,000
New +$21.8K ﹤0.01% 188

Other funds holding DRTSW

Clear Street's DRTSW Position: Q1 2026 in Review

Clear Street held its Alpha Tau Medical Warrant (DRTSW) position steady in Q1 2026 at 62,666 shares worth $62.7K. The position accounts for ﹤0.01% of the portfolio, ranked #696.

Clear Street first reported a position in DRTSW in Q1 2022 and has held it in 17 quarters since. 21 funds tracked by Wall St. Rank hold DRTSW as of Q1 2026.

  • Clear Street held 62,666 shares of Alpha Tau Medical Warrant worth $62.7K as of Q1 2026.
  • Clear Street left its Alpha Tau Medical Warrant share count unchanged in Q1 2026.
  • Alpha Tau Medical Warrant made up ﹤0.01% of Clear Street's portfolio in Q1 2026, its #696 holding.
  • Clear Street first reported a position in Alpha Tau Medical Warrant in Q1 2022 and has held it in 17 quarters since.
  • 21 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q1 2026.

Based on Clear Street's 13F filing for Q1 2026, filed 15 May 2026.